Leaflet HEPAXANE 15000UI (150mg)/1ml solution for injection in pre-filled syringe

Indicated for: prevention and treatment of thromboembolism

Route of administration: injectable

Substance: enoxaparin (anticoagulant)

ATC: B01AB05 (Blood and blood forming organs | Antithrombotic agents | Heparin group)

Precautions:
Dose adjustment in renal impairment
Dose adjustment in renal impairment

Dose adjustment may be needed in kidney disease.

Major drug interactions
Major drug interactions

This medicine may have important interactions with other medicines.

Additional monitoring
Additional monitoring

This medicine is subject to additional monitoring.

Breastfeeding warning
Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning
Pregnancy warning

Use during pregnancy only on medical advice.

Bleeding risk
Bleeding risk

This medicine may increase the risk of bleeding.

Enoxaparin is an anticoagulant medication used to prevent and treat blood clots (thrombosis). It belongs to the class of low molecular weight heparins (LMWH) and works by inhibiting clotting factors, particularly thrombin and factor Xa, thereby preventing the formation of blood clots.

Enoxaparin is indicated for the prevention of deep vein thrombosis (DVT), pulmonary embolism (PE), and thrombotic complications in patients with unstable angina or non-ST-elevation myocardial infarction (NSTEMI). It is also used to treat existing thrombosis and to prevent clot formation in immobilized patients or those undergoing surgery.

The medication is administered as subcutaneous injections, usually in the abdominal area, as directed by a healthcare provider. Side effects may include bleeding, hematomas at the injection site, nausea, or, rarely, allergic reactions and heparin-induced thrombocytopenia (HIT). It is important to use enoxaparin as prescribed and to inform the healthcare provider about other medications or pre-existing conditions to avoid complications.

General data about HEPAXANE 15000UI (150mg)/1ml

  • Substance: enoxaparin
  • Date of latest medicines list: 01-10-2021
  • Product code: W67319011
  • Concentration: 15000UI(150mg) / 1ml
  • Pharmaceutical form: solution for injection in pre-filled syringe
  • Quantity: 90
  • Product type: Generic medicine
  • Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

  • Manufacturer: ITALFARMACO S.P.A - ITALIA
  • Holder: CHEMI S.P.A - ITALIA
  • Number: 13236/2020/02
  • Shelf life: 3 years

Marketing authorisation

  • Manufacturer: ITALFARMACO S.P.A - ITALIA
  • Holder: CHEMI S.P.A - ITALIA
  • Number: 14938/2023/01
  • Shelf life: 3 years

Pharmaceutical forms available for enoxaparin

Concentrations available for enoxaparin

  • 10000UI(100mg)/1.0ml
  • 10000UI(100mg)/1ml
  • 100mg/ml
  • 12000UI(120mg)/0.8ml
  • 15000UI(150mg)/1ml
  • 2000ui anti-Xa/0.2ml
  • 2000UI(20mg)/0.2ml
  • 4000ui anti-Xa/0.4ml
  • 4000UI(40mg)/0.4ml
  • 6000ui anti-Xa/0.6ml
  • 6000UI(60mg)/0.6ml
  • 8000ui anti-Xa/0.8ml
  • 8000UI(80mg)/0.8ml